3D Cell Culture Market by product (Scaffold-based, 3D Cell Cultures Scaffold-free, 3D Cell Cultures, Micro fluidics-based, 3D Cell Cultures Magnetic & Bioprinted, and 3D Cell Cultures), By Mode of Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology, and Testing Tissue Engineering & Regenerative Medicine), By End User (Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetics Industry, and Other End Users)and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and America – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028

Report Code : BII929 Jan-2022 Healthcare Format : PDF Pages : 208

     



3D Cell Culture Market Overview

A 3D cell culture is an in-vitro procedure wherein the cells can fill in a falsely established climate. These conditions intently look like the design and working of the local tissue. 3D cell culture method invigorates cell separation, expansion, and relocation by cooperating with their three-layered environmental factors as they would in the in-vivo climate. As 3D cell societies can mirror the design, action, and microenvironment of the in-vivo tissues, this procedure has fluctuated applications in the fields of medication screening, regenerative medication, immature microorganism treatments, malignant growth exploration and cell science. The extracellular framework in 3D cell societies empowers cell correspondence by direct contact as in-vivo climate by discharging cytokines and trophic elements. The development of this market is driven chiefly by the rising spotlight on creating options in contrast to creature testing, developing spotlight on customized medication, expanding frequency of constant sicknesses, and the accessibility of subsidizing for research. Then again, the absence of framework for 3D cell-based research and the significant expense of cell science research are supposed to limit the development of this market during the gauge time frame.

Market Size

According to Business Intelligence Insights "3D Cell Culture Market is expected to grow from USD 982.90 million in 2021 to USD 3,070.1 million by 2028, at a CAGR of 15.30% during the forecast period 2022-2028


Covid -19 Impact Analysis

The COVID-19 pandemic has brought about cross-country lockdowns, in this manner affecting each industry vertical. In like manner, the 3D cell culture market is likewise impacted by the pandemic. The 3D cell culture industry is at present confronting more up to date difficulties to adapt up to the interest and supply of 3D cell culture parts attributable to the COVID-19 pandemic. Likewise, conflicting and hindered inventory network exercises and accessibility of HR are supposed to affect the market development. In actuality, flood in research rehearses for creating novel treatments against COVID-19 is filling in as an immense chance for the key market players.

Market Dynamics

•    Drivers
o    Versatile properties such as high strength and low price are expected to boost the global 3D Cell Culture market
o    Increasing chronic diseases
o    Increased demand from emerging economies

•    Restraints
o    Lack of skilled expertise and the high cost of technologies
o    Lack of infrastructure

Segmentation Insights


By Application 

Cancer research category dominated the market with more than 40% of the market share

 IN 2021, Cancer research segment is expected to be the biggest developing portion over the examination time frame. This is significantly credited to the benefits presented by 3D cell culture in disease research, these incorporate simplicity of adjusting cell multiplication and morphology, uncovering practical medication reaction, catching phenotypic heterogeneity, permitting trial control in quality articulation and cell conduct and addressing the growth microenvironment.

 

By End User

Biotechnology and Pharmaceutical category dominated the market with more than 46% of the market share

    On the basis end user the market in 2021, the biotechnology and Pharmaceutical produced the biggest income portion of more than 46% in 2021. 3D cell societies enjoy benefits concerning ideal oxygen and supplement inclinations, non-uniform openness of cells inside a spheroid to a medication, and practical cell-to-cell collaborations in contrast with 2D cell culture to concentrate on drug up-and-comers. These elements make 3D cell societies more qualified for drug disclosure and advancement, in this manner driving the interest.

By Product
•    Scaffold-based 
•    3D Cell Cultures Scaffold-free 
•    3D Cell Cultures 
•    Micro fluidics-based 
•    3D Cell Cultures Magnetic & Bioprinted 
•    3D Cell Cultures 

By Application 
•    Cancer & Stem Cell Research 
•    Drug Discovery & Toxicology 
•    Testing Tissue Engineering & Regenerative Medicine 

By End User
•    Pharmaceutical & Biotechnology Companies 
•    Research Institutes 
•    Cosmetics Industry 
•    Other End Users 

By Region
•    North America
o    U.S.
o    Canada
•    Europe
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
o    Rest of Europe
•    Asia Pacific
o    China
o    India
o    Japan
o    Rest of Asia Pacific
•    Latin America
o    Brazil
o    Mexico
o    Rest of Latin America
•    Middle East and Africa
o    UAE
o    South Africa
o    Rest of Middle East and Africa (MEA)

Key Players

List of Key Players in the 3D Cell Culture Market:

•    Thermo Fisher Scientific (US)
•    Corning Incorporated (US)
•    Merck KGaA (Germany)
•    Lonza AG (Switzerland) 
•    REPROCELL Incorporated (Japan)
•    TissUse (Germany)
•    InSphero (Switzerland) 
•    Synthecon (US)
•    3D Biotek (US) 
•    CN Bio (UK)
•    Hamilton Company (US) 
•    MIMETAS (Netherlands) 
•    Emulate (US)
•    Hµrel Corporation (US) 
•    QGel SA (Switzerland) 
•    SynVivo (US)
•    Advanced BioMatrix (US) 
•    Greiner Bio-One International (Austria)
•    PromoCell (Germany)

Regional Insights

World map title will be here...

US dominated the market with more than 40% of the market share

North America overwhelms the general 3D cell culture market with the United States being the significant supporter of the market. The United States is zeroing in on R&D and has been making huge interests in research on 3D cell culture, for the beyond couple of years. This has brought about innovative progressions in the country. Numerous American candidates include among the vitally patent candidates for the 3D cell culture area. American candidates will quite often foster their advancements in the United States, as well as in Asia.

Table

Report Attributes
Details
Market Size Value in 2021 USD 982.90 million
Market Size Value in 2027 USD 3,070.1 million
Growth Rate +15.30%
Base Year 2021
Forecast Period 2021-2030
Historical Data 2018-2020
Forecast Units (USD Million)
Countries Covered North America: U.S and Canada Europe: Germany, France, Italy, U.K, Spain, Russia, Rest of Europe APAC: China, Japan, South Korea, India, Australia, South East Asia, Rest of Asia Pacific Latin America: Brazil, Mexico Middle East And Africa: Saudi Arab, South Africa, UAE
Segments Covered By Product, By Application, By End User, By Region
Competitive landscape Leading companies, Competitive strategies and Consumer engagement scope
Customization is available If our report does not contain the information you require, you can contact our experts to have segments created for you. Please contact us at sales@businessintelligence-insights.com if you have any questions

 

Frequently Asked Questions (FAQ):

The 3D Cell Culture Market is predicted to grow at a 15.30% CAGR between 2022-2028.

According to Business Intelligence Insights 3D Cell Culture Market is expected to grow from USD 982.90 million in 2021 to USD 3,070.1 million by 2028, at a CAGR of 15.30% during the forecast period 2022-2028

US dominated the market with more than 40% of the market share

Key competitors in the 3D Cell Culture Market include Thermo Fisher Scientific (US) , Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US) , 3D Biotek (US), CN Bio (UK) , Hamilton Company (US) , MIMETAS (Netherlands)

Biotechnology and Pharmaceutical category dominated the market with more than 46% of the market share
Purchase Options
Copyright © Business Intelligence Insights.